Kenvue Inc. (KVUE) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Kenvue Inc. (KVUE) stock forecast summary
On Oct. 14, 2026, KVUE is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
Kenvue Inc. is a large-cap company with a market capitalization of $34.11B. It ranks number 3 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for KVUE is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.7% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, KVUE included.
Follow KVUE freeKVUE price chart and AI forecast
How KVUE ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Kenvue Inc. (KVUE) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Valuation & Market
| Metric | KVUE | Rank |
|---|---|---|
| Market Cap | $34.11B | 3/16 |
| P/E Ratio | 20.57x | 5/7 |
| P/B Ratio | 3.23x | 6/13 |
| Dividend Yield | 4.67% | 1/6 |
| EPS | $0.78 | – |
| Book Value/Share | $5.49 | – |
| Revenue/Share | $8.02 | – |
| FCF/Share | $1.00 | – |
Profitability & Margins
| Metric | KVUE | Rank |
|---|---|---|
| ROE | 15.7% | 5/13 |
| ROA | 6.2% | 5/16 |
| ROIC | 12.6% | 5/12 |
| Gross Margin | 58.2% | 7/14 |
| Operating Margin | 17.1% | 3/15 |
| Net Margin | 10.8% | 3/15 |
| EBT Margin | 14.4% | 3/15 |
| Tax Rate | 25.4% | – |
Financial Health
| Metric | KVUE | Rank |
|---|---|---|
| Current Ratio | 1.01x | 13/16 |
| Quick Ratio | 0.71x | 13/16 |
| D/E Ratio | 1.53x | 6/14 |
| Financial Leverage | 2.53x | 6/14 |
| Interest Coverage | 6.8x | 5/13 |
| Working Capital | $32M | 8/16 |
Cash Flow
| Metric | KVUE | Rank |
|---|---|---|
| Operating Cash Flow | $2.33B | 2/17 |
| Free Cash Flow | $1.91B | 2/11 |
| Capital Spending | -$411M | 9/11 |
| OCF Growth YoY | 11.2% | 7/10 |
| FCF Growth YoY | 17.2% | 8/9 |
| FCF/Sales | 12.4% | 6/11 |
| CapEx/Sales | 2.7% | 5/11 |
Operational Efficiency
| Metric | KVUE | Rank |
|---|---|---|
| Asset Turnover | 0.58x | 11/14 |
| Receivables Turnover | 6.2x | 10/12 |
| Inventory Turnover | 3.7x | 5/13 |
| Fixed Assets Turnover | 6.9x | 9/13 |
| Days Sales Outstanding | 59 days | 3/12 |
| Days Inventory | 98 days | 8/13 |
| Payables Period | 146 days | 2/12 |
| Cash Conversion Cycle | 10 days | 9/11 |
Income Statement
| Metric | KVUE | Rank |
|---|---|---|
| Total Revenue | $15.41B | 2/14 |
| Operating Income | $2.63B | 2/16 |
| Net Income | $1.66B | 2/16 |
| R&D Expense | $370M | 1/5 |
| SG&A Expense | $6.04B | 3/12 |
| Cost of Goods Sold | $6.44B | 2/15 |
Dividend & Shareholder Information
| Metric | KVUE | Rank |
|---|---|---|
| Dividends Per Share | $0.83 | – |
| Payout Ratio | 106.4% | – |
| Shares Outstanding | 1921M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $5.90B | 22.1% of assets |
| Cash & Short-term Investments | $1.11B | 4.2% of assets |
| Accounts Receivable | $2.48B | 9.3% of assets |
| Inventory | $1.72B | 6.4% of assets |
| Total Liabilities | $16.18B | 60.5% of assets |
| Short-term Debt | $3.29B | 12.3% of assets |
KVUE quarterly financials and insider trading
Kenvue Inc. (KVUE) industry peers
Companies classified under the same SEC industry code as Kenvue Inc. (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| KVUE Kenvue Inc. | ▶ | $34.11B |
| CL Colgate Palmolive Co | ▼ | $71.71B |
| EL Estee Lauder Companies Inc | ▼ | $36.08B |
| ELF E.L.F. Beauty, Inc. | ▼ | $6.38B |
| IPAR Interparfums Inc | ▼ | $3.65B |
| COTY Coty Inc. | ▲ | $2.60B |
| EPC Edgewell Personal Care Co | ▼ | $1.31B |
| WALD Waldencast Plc | ▲ | $97M |
| SLSN Solesence, Inc. | ▲ | $70M |
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| AXIL Axil Brands, Inc. | ▶ | $40M |
| UG United Guardian Inc | ▲ | $32M |
| DQWS Dswiss Inc | ▶ | $17M |
| CABR Caring Brands, Inc. | ▲ | $14M |
| BNKK Bonk, Inc. | ▶ | $10M |
| YCBD Cbdmd, Inc. | ▲ | $4M |
| HLN Haleon Plc | ▼ | N/A |
| KARX Karbon-X Corp. | ▼ | N/A |
| ODD Oddity Tech Ltd | ▶ | N/A |
Where KVUE sits on the market map
Kenvue Inc. (KVUE) stock news
Loading...
Kenvue Inc. (KVUE) stock forecast FAQ
What is the Kenvue Inc. (KVUE) stock forecast?
On Oct. 14, 2026, KVUE is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
How accurate are Kenvue Inc. stock predictions?
A per-ticker accuracy statistic for KVUE is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Kenvue Inc. forecasts updated?
Kenvue Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Kenvue Inc.'s industry peers?
19 issuers in our coverage, KVUE included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Estee Lauder Companies Inc (EL), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY), Edgewell Personal Care Co (EPC).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.